APP/PS1双转基因小鼠早期记忆功能障碍与胆碱能系统的关系研究

目的观察转APP/PS1基因阿尔茨海默病小鼠(APP/PS1小鼠)早期空间学习记忆功能及乙酰胆碱能系统的变化以及两者之间的相关性,探讨阿尔茨海默病早期学习记忆障碍的发病机制。方法应用Morris水迷宫法评定3月龄APP/PS1小鼠及相应野生型(WT)小鼠的空间学习记忆功能;采用免疫组织化学及组织化学染色方法检测脑组织中β-淀粉样蛋白(Aβ)斑块沉积情况;采用ELISA法检测脑组织中乙酰胆碱(ACh)含量以及胆碱乙酰转移酶(ChAT)和乙酰胆碱酯酶(AChE)活性,并探讨小鼠脑组织中ACh含量与其空间记忆能力、ChAT活性的相关性。结果水迷宫评定结果显示两组小鼠到达平台的潜伏期无统计学差异(P>0.05);APP/PS1小鼠在目标象限的游泳时间百分比〔(29.02±4.27)%〕和距离百分比〔(28.85±3.77)%〕较WT小鼠均下降(P<0.05)。APP/PS1小鼠脑组织中尚无Aβ斑块的沉积。APP/PS1小鼠脑组织中ACh含量〔(45.23±1.40)ng/g prot〕和ChAT活性〔(279.53±12.13)U/g组织湿重〕均较WT小鼠〔分别为(54.08±4.84)ng/gprot、(315.84±11.32)U/g组织湿重〕显著降低(P<0.05),两组小鼠脑组织中AChE活性无统计学差异(P>0.05)。小鼠脑组织中ACh含量与其空间记忆功能(目标象限航行时间百分比、目标象限航行路程百分比)呈正相关(r=0.861、r=0.874,P<0.05),ACh含量与ChAT活性呈正相关(r=0.926,P<0.05)。结论 APP/PS1小鼠空间记忆功能障碍、ACh含量减少和ChAT活性降低可发生于Aβ斑块沉积之前。脑组织中ACh含量减少和ChAT活性降低可能与APP/PS1小鼠记忆功能损害密切相关。     

Antisense inhibition of acetylcholinesterase gene expression for treating cognition deficit in Alzheimer's disease model mice

To examine whether the selected antisense oligodeoxynucleotides (AS-ODN) targeting against human brain acetylcholinesterase (AChE) mRNA could improve the cognitive deficit in the Alzheimer's disease (AD) model mice induced by amyloid-beta peptide (Abeta), we determined the time-effect relationship of AChE activity and the learning and memory after AS-ODN delivery. The results showed that the AChE activity decreased gradually along with time, initiating at 8 h and lasting 42 h. The time-effect curves of acetylcholine (ACh) behaved consistency with that of AChE activity. The animal cognition studies showed that in step-through test, the error number of the AS-ODN-treated AD model mice was significantly decreased, and the memory retention was increased. In the water maze performance, the swimming time obviously shortened. Our results indicated that antisense therapy is of potential use in the treatment of cognitive deficit in the Abeta model mice.     

盐酸美金刚对血管性痴呆大鼠疗效观察

目的 观察盐酸美金刚对血管性痴呆大鼠的疗效及作用机制.方法 80只健康Wistar大鼠(月龄12～14个月),体质量300～400 g,随机分为对照组、模型组、美金刚对照组及美金刚治疗组,每组20只.采用持久双侧颈总动脉结扎术造成血管性痴呆大鼠模型,美金刚对照组及美金刚治疗组于术后8周开始以美金刚(5 mg·kg-1)每天灌胃,对照组和模型组以同等量的0.5 g/L羧甲基纤维素钠灌胃,连续4周.采用Morris水迷宫衡量大鼠学习记忆水平;测定大鼠脑皮层、海马组织乙酰胆碱酯酶(AChE)、胆碱乙酰转移酶(ChAT)、丙二醛(MDA)、谷胱甘肽(GSH)活性的变化.结果 术后12周,与对照组相比,模型组大鼠的学习记忆能力明显下降(P<0.05);脑皮层、海马组织内AChE活性明显升高(P<0.05),ChAT活性明显降低(P<0.05),MDA活性明显升高(P<0.05),GSH活性明显降低(P<0.05);与模型组相比,美金刚治疗组大鼠的学习记忆能力明显提高(P<0.05);脑皮层、海马组织内AChE活性及ChAT活性差异无统计学意义(P>0.05)、MDA活性明显降低(P<0.05)、GSH活性明显升高(P<0.05).结论 盐酸美金刚对血管性痴呆大鼠的学习记忆能力有明显提高,作用机制是通过调节脑组织内MDA及GSH的活性来实现的,该实验研究为临床上血管性痴呆的治疗提供实验基础及理论依据.     

D-半乳糖和铝联合应用诱导大脑产生阿尔茨海默病样损伤(英文)

目的 D-半乳糖能制作亚急性衰老模型,铝具有神经毒性,但两者联合应用的作用未见报道。本研究旨在探讨D-半乳糖和铝联合应用对动物学习记忆、脑内生化和病理的影响,以及与单独应用D-半乳糖或铝所制作的动物模型相比较。方法昆明小鼠单独皮下注射D-半乳糖、单独灌胃铝以及既注射D-半乳糖又灌胃铝,制作动物模型,共给药8周或10周,10周后再停用药物6周。在第8、10、16周末,采用Morris水迷宫检测小鼠学习记忆能力,生化学方法检测脑内乙酰胆碱能系统,免疫组化法检测老年斑和神经原纤维缠结的形成。结果联合应用D-半乳糖和铝后,小鼠表现出明显的学习和记忆力障碍,并且其脑内乙酰胆碱水平降低,乙酰胆碱转移酶和胆碱脂酶活性下降,出现老年斑样和神经原纤维缠结样病理改变。停止给药后,其行为学、生化和病理改变至少能维持6周以上。结论小鼠中D-半乳糖和铝联合应用是一个有效的非转基因阿尔茨海默病(Alzheimer’sdisease,AD)模型,可用于AD病理研究和相关治疗药物的评价。     

乙酰胆碱特征超低频经颅磁刺激对阿尔茨海默病模型大鼠记忆力的影响

目的探索乙酰胆碱特征超低频经颅磁刺激(ACh-TMS)对阿尔茨海默病(AD)模型大鼠学习记忆力的影响及其机制。方法 SD大鼠随机分为正常组(N组)、模型组(M组)、假手术组(P组)、假刺激组(M+P组)、乙酰胆碱特征超低频磁刺激组(ACh-TMS组)和多奈哌齐组(donepezil组),每组10只。双侧海马注射Aβ1-42建立AD模型。Morris水迷宫实验观察大鼠学习记忆力。检测海马组织脑源性神经营养因子(BDNF)及乙酰胆碱(ACh)含量、乙酰胆碱酯酶(AChE)及胆碱乙酰转移酶(Ch AT)活力变化。改良Highman刚果红法观察淀粉样物质沉积情况。结果与M+P组比较,ACh-TMS组大鼠平均逃避潜伏期缩短、目标象限游泳时间百分比及跨越平台次数明显增多(P0.05);BDNF、ACh含量及Ch AT活力显著提高(P0.05)。除N组和P组外,其余各组大鼠海马区可见淀粉样物质沉积。结论 ACh-TMS可改善AD模型大鼠学习记忆力,其机制可能与提高中枢胆碱能递质含量、促进海马BDNF表达有关。     

Acetylcholine and acetyl-CoA metabolism in differentiating SN56 septal cell line.

The rate of acetylcholine (ACh) synthesis was found to depend on the activity of choline acetyltransferase (ChAT) and on the concentrations of the two substrates of this enzyme, choline and acetyl-CoA. In SN56 cells treated for 3 days with 1 mM dbcAMP activities of ChAT and acetylcholinesterase (AChE) were elevated. It was accompanied by an increased activity of ATP-citrate lyase (ACL)-an enzyme responsible for provision of part of acetyl-CoA for ACh synthesis in cholinergic neurons. In contrast lactate dehydrogenase (LDH) and pyruvate dehydrogenase (PDH) activities were reduced by dbcAMP. Treatment with 0.001 mM all-trans retinoic acid (RA) elevated ChAT and LDH activities but reduced the activities of AChE and ACL. The combined treatment with db-cAMP and tRA increased ChAT activity in supra-additive fashion. The effects of these two compounds on the other enzymes were not additive. Neither compound altered the activities of carnitine acetyl-transferase, acetyl-CoA synthase, or acetyl-CoA hydrolase. On the other hand, they decreased acetyl-CoA content and rate of ACh release. Overall, the results indicate that tRA upregulates only ChAT expression, whereas dbcAMP upregulates several features of cholinergic neurons including ChAT, AChE, and ACL. Low levels of acetyl-CoA in differentiated cells may result in a low rate of ACh release and resynthesis during their depolarization.     

Human neural stem cells over-expressing choline acetyltransferase restore cognition in rat model of cognitive dysfunction

A human neural stem cell (NSC) line over-expressing human choline acetyltransferase (ChAT) gene was generated and these F3.ChAT NSCs were transplanted into the brain of rat Alzheimer disease (AD) model which was induced by application of ethylcholine mustard aziridinium ion (AF64A) that specifically denatures cholinergic nerves and thereby leads to memory deficit as a salient feature of AD. Transplantation of F3.ChAT human NSCs fully recovered the learning and memory function of AF64A animals, and induced elevated levels of acetylcholine (ACh) in cerebrospinal fluid (CSF). Transplanted F3.ChAT human NSCs were found to migrate to various brain regions including cerebral cortex, hippocampus, striatum and septum, and differentiated into neurons and astrocytes. The present study demonstrates that brain transplantation of human NSCs over-expressing ChAT ameliorates complex learning and memory deficits in AF64A-cholinotoxin-induced AD rat model.     

Evidences for B6C3-Tg (APPswe/PSEN1dE9) Double-Transgenic Mice Between 3 and 10 Months as an Age-Related Alzheimer’s Disease Model

Transgenic mouse has shown great advantages in the study of Alzheimer’s disease (AD) and drug screening as AD develops rapidly resent years, while more detail information of these transgenic mice and experience of application are needed. To obtain the basic background information of the B6C3-Tg (APPswe/PSEN1dE9) double-transgenic mouse, which was reported with early onset AD, three- to ten-month-old B6C3-Tg AD mice and normal C57BL/6 mice were selected randomly to test the ability of learning memory by Morris water maze, the brain acetylcholinesterase (AChE) activity by AChE kit, and beta amyloid protein level by immunohistochemistry staining. Compared with the control group, the escape latency time of B6C3-Tg AD mice at 9 and 10 months of age is significantly longer (P?<?0.05) in Morris maze test, and the activity of brain AChE is higher. β-Amyloid plaques were observed at 3 months of age and developed rapidly. Statistical analysis showed a positive correlation between the area of these plaques and the ages of B6C3-Tg AD mouse (y?=?0.0355e^0.5557x, R?=?0.9557). The model’s behavior is conformed to simulate behaviors of human Alzheimer’s disease at the early stage and may provide detail background information a new choice when transgenic mice are needed in the research of AD.     

Puerarin attenuates learning and memory impairments and inhibits oxidative stress in STZ-induced SAD mice

Puerarin (PUE), an isoflavone purified from the root of Pueraria lobata (Chinese herb), has been reported to attenuate learning and memory impairments in the transgenic mouse model of Alzheimer's disease (AD). In the present study, we tested PUE in a sporadic AD (SAD) mouse model which was induced by the intracerebroventricular injection of streptozotocin (STZ). The mice were administrated PUE (25, 50, or 100 mg/kg/d) for 28 days. Learning and memory abilities were assessed by the Morris water maze test. After behavioral test, the biochemical parameters of oxidative stress (glutathione peroxidase (GSH-Px), superoxide dismutases (SOD), and malondialdehyde (MDA)) were measured in the cerebral cortex and hippocampus. The SAD mice exhibited significantly decreased learning and memory ability, while PUE attenuated these impairments. The activities of GSH-Px and SOD were decreased while MDA was increased in the SAD animals. After PUE treatment, the activities of GSH-Px and SOD were elevated, and the level of MDA was decreased. The middle dose PUE was more effective than others. These results indicate that PUE attenuates learning and memory impairments and inhibits oxidative stress in STZ-induced SAD mice. PUE may be a promising therapeutic agent for SAD.     

Which memory task for my mouse? A systematic review of spatial memory performance in the Tg2576 Alzheimer's mouse model

We review studies testing performance on tasks putatively tapping spatial memory in the Tg2576 mouse model of Alzheimer's disease (AD). This model exhibits age-dependent elevation of amyloid-β in the hippocampal formation and elsewhere in the brain. From 49 articles in all, we reviewed Tg2576 performance on five spatial memory tasks: the reference memory version of the Morris water maze, continuous Y-maze alternation, discrete forced-choice T-maze alternation, the radial arm water maze, and the circular platform maze (Barnes maze). Proportionally, the likelihood of detecting significant impairment in Tg2576 mice (relative to age-matched controls) was found to be: highest with the use of T-maze alternation and the radial arm water maze; intermediate when using the Morris water maze and continuous Y-maze alternation; and lowest when using the circular platform maze. These results are indicative rather than conclusive, but have implications for testing cognitive function in Tg2576 mice and, potentially, other AD rodent models. The apparent sensitivity of the T-maze alternation task and reduced sensitivity of the Morris water maze task (reference memory version) are discussed. We also consider limitations and potential improvements in assessing cognitive impairment in dementia models.     

Strain differences in the expression of cholinergic markers in the hippocampus of ApoE-knockout and C57BL/6J mice

Our recent study suggests that mice deficient in ApoE may exhibit impaired learning and memory. Here we designed the present study to investigate the association between ApoE deficiency and cholinergic markers expression in the hippocampus of ApoE-knockout (ApoE-KO) and wild-type (WT) mice. Hippocampal slices were collected and the mRNA levels of choline acetyltransferase (ChAT) and acetylcholinesterase (AChE) and the protein level of ChAT were analyzed. We show that ApoE-KO exhibited a distinctly lower ChAT mRNA and protein levels in the hippocampus compared with WT mice. There were no strain effects on AChE mRNA. Our data provide evidence supporting the role of ApoE in the expression of ChAT, which may suggest a possible link between cholinergic deficit and poorer performance in ApoE-KO mice.     

Dual Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase Blockade Produces THC-Like Morris Water Maze Deficits in Mice

Acute administration of Δ(9)-tetrahydrocannabinol (THC) or exposure to marijuana smoke impairs short-term spatial memory in water maze tasks through a CB(1) receptor mechanism of action. N-Arachidonoylethanolamine (anandamide; AEA) and 2-arachidonoylglycerol (2-AG) are endogenous cannabinoids that are predominantly metabolized by the respective enzymes fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL). Although the MAGL inhibitor JZL184 enhances short-term synaptic plasticity, it has yet to be evaluated in the Morris water maze. Previous research demonstrated that simultaneous, complete blockade of FAAH and MAGL produces full blown THC-like effects. Thus, in the following studies we tested whether dual blockade of FAAH and MAGL would impair learning in a repeated acquisition Morris water maze task. Mice treated with the dual FAAH/MAGL inhibitor JZL195 (20 mg/kg) as well as JZL184-treated FAAH -/- mice displayed robust deficits in Morris water maze performance that were similar in magnitude to THC-treated mice. While 20 or 40 mg/kg impaired water maze performance in FAAH -/- mice, only the high dose of JZL184 disrupted performance in FAAH +/+ mice. The memory impairing effects of JZL184 were blocked by the CB(1) receptor antagonist rimonabant. Neither JZL184 nor JZL195 impaired performance in a cued version of the water maze task, arguing against the notion that sensorimotor or motivational deficits accounted for the impaired acquisition performance. JZL184 increased 2-AG levels in the hippocampus, prefrontal cortex, and cerebellum to a similar degree in FAAH -/- and +/+ mice. FAAH -/- mice, regardless of drug treatment, possessed elevated AEA levels in each brain region assessed. The results of this study reveal that concomitant increases in AEA and 2-AG disrupt short-term spatial memory performance in a manner similar to that of THC.     

α-分泌酶ADAM10对APP转基因小鼠情绪和学习行为的影响

目的探讨α-分泌酶ADAM10对阿尔茨海默病发生的作用。方法采用开场实验、高架十字迷宫和水迷宫实验测试并比较APP转基因小鼠和APP/ADAM10双转基因小鼠的行为学差异。结果与对照组小鼠相比,APP转基因小鼠焦虑性增高,自主活动力减弱,空间学习记忆力下降,差异有显著性(P<0.05);而APP/ADAM10双转基因小鼠各种行为和对照组相比无显著性差异(P>0.05)。结论α-分泌酶ADAM10能显著改善小鼠的情绪,提高APP转基因小鼠的自主活动力和学习、记忆能力,开发激活AD-AM10酶活性的药物或者在神经细胞表达ADAM10可望成为治疗阿尔茨海默病的新途径。     

The basal forebrain cholinergic system in aging and dementia. Rescuing cholinergic neurons from neurotoxic amyloid-β42 with memantine

The dysfunction and loss of basal forebrain cholinergic neurons and their cortical projections are among the earliest pathological events in the pathogenesis of Alzheimer's disease (AD). The evidence pointing to cholinergic impairments come from studies that report a decline in the activity of choline acetyltransferase (ChAT) and acetylcholine esterase (AChE), acetylcholine (ACh) release and the levels of nicotinic and muscarinic receptors, and loss of cholinergic basal forebrain neurons in the AD brain. Alzheimer's disease pathology is characterized by an extensive loss of synapses and neuritic branchings which are the dominant scenario as compared to the loss of the neuronal cell bodies themselves. The appearance of cholinergic neuritic dystrophy, i.e. aberrant fibers and fiber swelling are more and more pronounced during brain aging and widely common in AD. When taking amyloid-β (Aβ) deposition as the ultimate causal factor of Alzheimer's disease the role of Aβ in cholinergic dysfunction should be considered. In that respect it has been stated that ACh release and synthesis are depressed, axonal transport is inhibited, and that ACh degradation is affected in the presence of Aβ peptides. β-Amyloid peptide 1-42, the principal constituent of the neuritic plaques seen in AD patients, is known to trigger excess amount of glutamate in the synaptic cleft by inhibiting the astroglial glutamate transporter and to increase the intracellular Ca²⁺ level. Based on the glutamatergic overexcitation theory of AD progression, the function of NMDA receptors and treatment with NMDA antagonists underlie some recent therapeutic applications. Memantine, a moderate affinity uncompetitive NMDA receptor antagonist interacts with its target only during states of pathological activation but does not interfere with the physiological receptor functions. In this study the neuroprotective effect of memantine on the forebrain cholinergic neurons against Aβ42 oligomers-induced toxicity was studied in an in vivo rat dementia model. We found that memantine rescued the neocortical cholinergic fibers originating from the basal forebrain cholinergic neurons, attenuated microglial activation around the intracerebral lesion sides, and improved attention and memory of Aβ42-injected rats exhibiting impaired learning and loss of cholinergic innervation of neocortex.     

The effects of cholinergic drugs and cholinergic-rich foetal neural transplants on alcohol-induced deficits in radial maze performance in rats.

Chronic alcohol (20% v/v in drinking water for 28 weeks) impaired acquisition of radial maze spatial and associative tasks by increasing both within-trial working and long-term reference memory errors; animals with high (above the median of 100 mg/100 ml) blood alcohol concentrations (BACs) during treatment were significantly more impaired than those with BACs below the median. Alcohol-treated rats showed improvements in radial maze performance after treatment with cholinergic agonists (arecoline and nicotine) and disruption with antagonists (scopolamine and mecamylamine) at low doses which did not affect controls. These effects were more pronounced for working than reference memory, and not manifest with the peripherally acting antagonists hexamethonium and N-methylscopolamine. Transplants into cortex and hippocampus of cholinergic-rich basal forebrain (BF) and ventral mesencephalon (VM) foetal neural tissue improved radial maze performance of alcohol-treated rats to control level over a period of 9-12 weeks after grafting. Cholinergic-poor foetal hippocampal (HC) grafts were without effect. BF and VM, but not HC, grafts showed dense acetylcholinesterase (AChE) staining, tyrosine-hydroxylase staining was most pronounced in VM sections and dopamine-beta-hydroxylase staining was minimal in all grafts. Choline acetyltransferase (ChAT) activity was significantly reduced in cortex and hippocampus of alcohol-treated rats, except those given cholinergic-rich transplants. Alcohol treatment also significantly reduced AChE-positive cell counts in the nucleus basalis, medial septal and diagonal band brain areas, at the sources of the forebrain cholinergic projection system (FCPS). Cortical levels of noradrenaline were significantly reduced in all alcohol-treated rats, regardless of transplant, whereas cortical dopamine content was significantly elevated in all rats receiving transplants, regardless of behavioural effect, but not in alcohol-treated controls. Forebrain serotonin levels were not significantly altered by grafting or alcohol treatment. These results suggest that damage to the FCPS, as shown by reduced ChAT activity in target areas, and reduced AChE cell counts in projection areas, played an important part in the radial maze deficits displayed by alcohol-treated rats, since these animals were sensitive to cholinergic drug challenge, and cholinergic-rich transplants from two different sites in foetal brain elevated ChAT activity and restored cognitive function. In contrast alcohol- or graft-induced alterations in other transmitter systems did not correlate with the pattern of behavioural deficit and recovery.     

Removing zinc from synaptic vesicles does not impair spatial learning, memory, or sensorimotor functions in the mouse

Zinc-enriched (ZEN) neurons are distributed widely throughout the brain and spinal cord. Synaptic vesicle zinc in these neurons is thought to function as a neuromodulator upon its release into the synaptic cleft. Consistent with this possibility, zinc or zinc chelators can alter spatial learning, working memory, and nociception in rodents. Here we use zinc transporter-3 (ZnT3) knockout mice, which are depleted of synaptic vesicle zinc, to assess the consequences of removing this potential neuromodulator on the behavior of adult mice. ZnT3 knockout mice performed equally as well as wild-type mice in the rotarod, pole, and cagetop tests of motor coordination. They exhibited normal thermal nociception in the hot-plate and tail-flick tests, and had similar olfactory, auditory and sensorimotor gating capabilities as wild-type mice. ZnT3 knockout mice behaved similarly as wild-type mice in the open field test and in the elevated plus maze test of anxiety. They exhibited normal learning and memory in the passive avoidance, Morris water maze, and fear conditioning tasks, and normal working and reference memory in a water version of the radial arm maze. We conclude that synaptic vesicle zinc is not essential for mice to be able to perform these tasks, despite the abundance of ZEN neurons in the relevant regions of the CNS. Either the neuromodulatory effects of zinc are not relevant for the tasks tested here, or mice are able to compensate easily for the absence of synaptic vesicle zinc.     

Effects of subchronic exposure to benzo[a]pyrene (B[a]P) on learning and memory, and neurotransmitters in male Sprague-Dawley rat

The harmful effects of the environmental carcinogen, benzo[a]pyrene (B[a]P), on mammalian neurodevelopment and behavior as yet remain unclear. Several studies have suggested that B[a]P impairs learning and memory. In the present investigation, we investigated the effects of subchronic exposure to B[a]P on rats. Male rats received daily injection of B[a]P (0, 1.0, 2.5, and 6.25 mg/kg, i.p.) or vehicle for 13 weeks. Employing the Morris water maze (MWM) test, we observed that rats exposed to either 2.5 mg/kg or 6.25 mg/kg B[a]P had modified behavior compared to controls as indicated by the increased mean latencies, the decreased number of crossing platform and the decreased swimming time in the target area. B[a]P treatment decreased the levels of malondialdehyde (MDA), nitric oxide (NO), nitric oxide synthase (NOS), superoxide dismutase (SOD), acetylcholine (ACh), choline acetyltransferase (ChAT), and increased the activity of acetylcholinesterase (AChE). Endogenous monoamine levels, norepinephrine (NE), adrenaline (A), dopamine (DA) and 5-hydroxytryptamine (5-HT) and their selected metabolites dihydroxyphenylacetic acid (DOPAC) and 5-hydroxyindoleacetic acid (5-HIAA) in hippocampus were measured using high performance liquid chromatography (HPLC). B[a]P at both doses, 2.5 and 6.25 mg/kg, increased NE, DA, DOPAC and 5-HT content in the hippocampus. Our results suggested a close link between the modified levels of neurotransmitters in the hippocampus and the impaired behavioral performance, indicating that B[a]P is a potential neurotoxic pollutant.     

Loss of neurons in the rat basal forebrain cholinergic projection system after prolonged intake of ethanol

A reduction in the number of acetylcholinesterase (AChE)-positive neurons in the basal nucleus of Meynert complex (NbM, Ch 1 to Ch4) to 83% of control values was observed in rat after ethanol intake (20% v/v) for 12 weeks. Activity of choline acetyltransferase (ChAT) and AChE in the basal forebrain was simultaneously reduced to 74% and 81% and content of acetylcholine (ACh) to 56% of control values respectively. Neuronal loss showed a gradient over the rostro-caudal extension of the cholinergic projection system being most pronounced in the septal-diagonal band area and reaching 27% in the medial septum (Ch1). Number of AChE-positive neurons was insignificantly reduced in the pedunculopontine nucleus (Ch5) and unchanged in the laterodorsal tegmental gray of the periventricular area (Ch6). ACh content and activity of AChE was significantly reduced in target areas of the NbM such as cortex, hippocampus and amygdala, but changes were less pronounced than in the basal nucleus. The results indicate a neurotoxic effect of prolonged intake of ethanol on cholinergic neurons in the NbM leading to a partial cholinergic denervation of cortex, hippocampus and amygdala. Chronic intake of ethanol in rat is suggested to represent an animal model suitable to test the cholinergic hypothesis of geriatric memory dysfunction and to develop strategies for an amelioration of the impairment in memory and cognitive function in dementing disorders associated with a degeneration in the NbM such as postalcoholic dementia and Alzheimer's disease.     

Cognitive-enhancing effects of fibrauretine on Aβ1–42-induced Alzheimer's disease by compatibilization with ginsenosides

Fibrauretine is the main active ingredient in rattan stems of Fibraurea recisa Pierre. The aim of this study was to evaluate the cognitive-enhancing effects and underlying molecular mechanisms of fibrauretine compatibilized with ginsenosides on Alzheimer's disease (AD) induced in mice with amyloid β-protein (Aβ_1–42)_. The results showed that the spatial learning and memory abilities of AD mice were significantly enhanced after combined treatment with fibrauretine and ginsenosides using the Morris water maze test. The levels of acetylcholinesterase (AChE) and phosphorylated Tau protein (p-Tau) in brain tissue and the levels of nitric oxide (NO), malondialdehyde (MDA), and N-terminal pro-brain natriuretic peptide (NT-proBNP) in plasma were significantly increased in Aβ_1–42-induced AD mice, and these effects were reversed after combined treatment with fibrauretine and ginsenosides. By contrast, a significant increase in the levels of catalase (CAT), superoxide dismutase (SOD), choline acetyltransferase (ChAT) and glutathione peroxidase (GSH-Px) was observed in the combined treatment group. The results of haematoxylin and eosin (H&E) staining, terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labelling (TUNEL) analysis, immunohistochemistry (IHC) and Western blot analysis showed that the apoptosis rate, Bax, nuclear factor kappa-B p65 (NF-κBp65), cleaved caspase-3 and cleaved caspase-9 expression levels were obviously decreased and that the Bcl-2 expression levels were significantly increased in the hippocampi of mice treated with fibrauretine and ginsenosides. The results of this study show that the ameliorative effect of fibrauretine against AD can be significantly enhanced by compatibilization with ginsenosides. The underlying molecular mechanisms of fibrauretine may be related to antioxidation and anti-apoptosis.     

Behavioral performance of tfm mice supports the beneficial role of androgen receptors in spatial learning and memory

In adulthood, androgens and androgen receptors might contribute to the sexually dimorphic performance in spatial learning and memory, but their roles seem complex. To study the potential role of androgen receptors in spatial learning and memory, we tested adult 6-8-month-old mutant mice with a naturally occurring defect in the androgen receptor gene (testicular feminization mutant or tfm) and C57Bl/6J wild-type mice. Because the trait is X-linked, only tfm males are completely androgen insensitive while female tfm mice are heterozygous, carrying one wild-type and one tfm copy of the androgen receptor. Here we show that female tfm carrier mice outperform tfm male mice in the water maze, while there are no gender differences in water maze performance in wild-type mice. In tfm mice, there were no gender differences in measures of anxiety in the open field or plus maze or sensorimotor function, indicating that potential differences in these measures did not contribute to the differences observed in the water maze. There were no differences in tfm and wild-type female and male mice in emotional learning and memory in the passive avoidance test. These findings support a beneficial role for androgen receptors in spatial learning and memory.